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Chemistry methods and materials 
All reactions were performed in oven dried glassware under an atmosphere of argon gas unless otherwise 
stated. Dry solvents were purchased from Sigma-Aldrich and Acros or taken out of a solvent system from 
M. Braun. Dry reagents were ordered from Sigma-Aldrich, Fluka, Acros, ABCR and Roth. NMR spectra 
were recorded with Bruker DRX-500, DPX-400 and AVANCE-400 with the residual solvent signal as 
internal standard.
[1]
 The solvents are given with the data. Multiplicities are described using the following 
abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. 
13
C NMR spectra 
are reported as values in ppm relative to the residual solvent signal as internal standards.
[1]
 The 
multiplicities are elucidated using the distortionless enhancement by polarisation transfer (DEPT) spectral 
editing technique, with secondary pulses at 90° and 135°. Multiplicities are reported using the following 
abbreviations: q (quarternary carbon), t (tertiary carbon = methine), s (secondary carbon = methylene), p 
= (primary carbon = methyl). High resolution mass spectra are obtained with a Micromass LCT via loop-
mode injection from a Waters (Alliance 2695) HPLC system. Alternatively a Micromass Q-TOF in 
combination with a Waters Aquity Ultraperformance LC system is employed. Ionisation is achieved by 
ESI or APCI. Modes of ionisation, calculated and found mass are given. Reversed phase-HPLC-
applications were performed with membrane-filtrated and double distilled water as well as commercial 
available HPLC-grade solvents (methanol or acetonitrile), which have been degased with ultrasound. 
Preparative HPLC was operated at a Merck Hitachi LaChrome HPLC (Pump L-7150, Interface D-7000, 
Diode Array Detector L-7450). The following stationary phases were used: (C18-SP) Trentec Reprosil-
Pur 120 C18 AQ 5µm, 250 mm * Ø 8 mm, corresponding precolumn cartridge, 40 mm * Ø 8 mm; (CN-
SP) Trentec Reprosil 100 CN 5µm, 250 nm * Ø 8 mm, corresponding precolumn cartridge, 40 mm * Ø 
8 mm. Alternatively preparative HPLC was performed with a Varian HPLC (Pumps Prepstar Model 218, 
Variable wavelength detector Prostar (λ = 248 nm) with parallel mass detection (Micromass Type ZMD 
ESI-Quad-Spectrometer) under use of a C18-P[B] stationary phase. Solvents, columns, operating 
procedures and retention times (tR) are given with the corresponding experimental and analytical data. 
(Abbreviations: PE= petroleum ether; EtOAc = ethyl acetate). 
Biochemistry methods and materials 
All chemicals and antibiotics were purchased from Sigma-Aldrich and Roth. E. coli BL21(DE3)-
CodonPlus-RP was purchased from Invitrogen. The expression constructs based on the pET-28a(+) 
vector and were prepared as stated previously.
[2]
 Cell disruption was conducted by French Press R 125 
from American Instrument Company. His-bind nickel chelate chromatography resin was purchased from 
Novagen.  Sartorius Vivaspin 20 ultrafiltration units (10,000 MW Cut-off), Millipore Amicon
®
 ultra 
centrifugal filters (30,000 MW Cut-off) and PD-10 desalting columns from GE Healthcare were used for 
protein concentration and buffer exchange respectively. 
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Synthetic procedures
[4]
 
Methyl (1R,2R)-2-((S,E)-1-((tert-butyldimethylsilyl)oxy)-5-oxopent-3-en-1-yl)cyclopentane-1-
carboxylate 
 
200 mg (640 µmol, 1.0 equiv.) 16 and 1.30 mL (15.8 mmol, 25 equiv.) crotonaldehyde were solved in 40 
mL CH2Cl2. 27 mg (32 µmol, 5 mol%) Grubbs II catalyst were added and it was heated to 40 °C under 
reflux for 2 h. All volatiles were removed under reduced pressure and the crude product was purified by 
flash chromatography on silica gel (petroleum ether:EtOAc (9:1)). After drying in vacuo, 192 mg (0.57 
mmol) of a brown oil were obtained (88% crude yield).  
The -unsaturated aldehyde showed a strong tendency to quickly oxidize to the carboxylic acid. 
Therefore, the crude product of the metathesis reaction was routinely analyzed by 
1
H NMR spectroscopy 
and TLC analysis. This material was subjected into the following reactions only after passing the crude 
product over a short filter column of silica gel. The amount that was inserted into the following reactions 
was calculated basing on the assumption of quantitative conversion in this step. 
Rf = 0.33 (PE/EtOAc 9:1); 
1
H NMR (200 MHz, CDCl3)  9.51 (d, J = 7.9 Hz, 1 H, HCO), 6.89 (dt, J1 = 
7.3 Hz, J2 = 15.6 Hz, 1 H, HC(O)CH), 6.05-6.18 (m, 1 H, HC(O)CHCH), 3.76-3.86 (m, 1 H, CHOTBS), 
3.65 (s, 3 H, COOCH3), 2.67-2.78 (m, 1 H, CHCOOCH3), 2.39-2.55 (m, 3 H, CH2CH2CH, 
CH2CHOTBS), 1.57-1.97 (m, 6 H, CH2CH2CH, CH2CHCOOCH3), 0.88 (s, 9 H, OSi(CH3)2C(CH3)3), 
0.07 (s, 3 H, OSi(CH3)2C(CH3)3), 0.06 (s, 3 H, OSi(CH3)2C(CH3)3). 
 
(1R,2R)-methyl 2-{(1S,5R,6R,E)-1-[(tert-butyldimethylsilyl)oxy]-5-hydroxy-6-methyl-7-oxo-7-
(phenylthio)hept-3-en-1-yl}cyclopentanecarboxylate 
 
613 µL (0.61 mmol, 3.6 equiv., 1 M in hexane) chlorodicyclohexylborane were dissolved in 7 mL Et2O 
and cooled to -78 °C. 81 µL (0.75 mmol, 4.4 equiv.) dimethylethylamine and 70 mg (0.42 mmol, 
2.5 equiv.) thiophenolpropionate were added dropwise and the reaction was stirred for 2 h at 0 °C. The 
reaction mixture was cooled to -78 °C and 60 mg (0.17 mmol, 1 equiv.) of the unsaturated aldehyde were 
added. The reaction was stirred for 1 h at -78 °C and then stored in a freezer at -20 °C for 18 h. 2 mL 
methanol, 2 mL phosphate buffer (pH 7) and 2 mL H2O2 (35%) were added to the solution and the 
mixture was stirred for 1 h at ambient temperature. The aqueous layer was three times extracted with 
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CH2Cl2 and the combined organic layers were dried over MgSO4. The solvent was removed in vacuo and 
the crude product was purified by flash chromatography on silica gel (petroleum ether:EtOAc (100:1) 
then petroleum ether:EtOAc (50:1) and petroleum ether:EtOAc (20:1)). After drying in vacuo, 50 mg 
(98.8 µmol) of a colourless oil, which consisted of an inseparable, approximately 1:1 mixture of both 
anti-aldol products, were obtained (57% yield over two steps). 
Rf = 0.17 (PE/EtOAc 9:1); 
1
H NMR (400 MHz, CDCl3)  7.42 (s, 5 H, CH(ar)), 5.68-5.77 (m, 1 H, 
CH3CH=CH), 5.42-5.42 (m, 1 H, CH3CH=CH), 4.26 (dd, J1 = 7.5 Hz, J2 = 7.5 Hz, 1 H, CHOH), 3.64-
3.69 (m, 1 H, CHOTBS), 3.66 (s, 3 H, OCH3), 2.87 (dq, J1 = 7.5 Hz, J2 = 7.0 Hz, 1 H, CH3CH), 2.73-2.79 
(m, 1 H, CH2CH2CH), 2.44-2.51 (m, 1 H, CHCOOCH3), 2.22-2.26 (m, 1 H, CH=CHCH2), 1.83-1.92 (m, 
1 H, CH2CHCOOCH3), 1.71-1.82 (m, 1 H, CH2CHCOOCH3, CH2CH2CH), 1.59-1.66 (m, 2 H, 
CH2CH2CH), 1.35-1.44 (m, 1 H, CH2CH2CH), 1.24 (d, J = 7.0 Hz, 3 H, CH3CH), 0.88 (s, 9 H, 
OSi(CH3)2C(CH3)3), 0.06 (s, 3 H, OSi(CH3)2C(CH3)3), 0.05 (s, 3 H, OSi(CH3)2C(CH3)3); 
13
C NMR (100 
MHz, CDCl3)  201.3 (q, 1 C, SCO), 177.7 (q, 1 C, COOCH3), 134.4 (t, 2 C, ArC), 132.3 (t, 1 C, 
CH=CHCH2), 130.2 (t, 1 C, CH=CHCH2), 129.4 (t, 2 C, ArC), 129.2 (t, 1 C, ArC), 127.5 (q, 1 C, ArC), 
75.1 (t, 1 C, CHOH), 74.4 (t, 1 C, CHOTBS), 53.7 (t, 1 C, CH3CH), 51.7 (p, 1 C, COOCH3), 47.2 (t, 1 C, 
CHCOOCH3), 44.4 (t, 1 C, CH2CH2CH), 38.9 (s, 1 C, CH=CHCH2), 32.1 (s, 1 C, CH2CHCOOCH3), 30.1 
(s, 1 C, CH2CH2CH), 26.1 (s, 1 C, CH2CH2CH), 25.9 (p, 3 C, OSi(CH3)2C(CH3)3), 18.0 (q, 1 C, 
OSi(CH3)2C(CH3)3), 15.0 (p, 1 C, CH3CH), -4.1 (p, 1 C, OSi(CH3)2C(CH3)3), -4.7 (p, 1 C, 
OSi(CH3)2C(CH3)3); HRMS (ESI) m/z calculated for C27H42O5SSiNa [M+Na]
+
: 529.2420, found: 
529.2422. 
 
(1R,2R)-methyl 2-[(5S,9R,10R,E)-9-hydroxy-2,2,3,3,10-pentanmethyl-11,16-dioxo-4-oxa-12-thia-15-aza-
3-silaheptadec-7-en-5-yl]cyclopentanecarboxylate 
 
10 mg (20 µmol, 1.0 equiv.) of the aldol product, 16 µL (91 µmol, 4.6 equiv.) DIPEA and 20 µL 
(188 µmol, 9.4 equiv.) HSNAC were dissolved in 1 mL DMF and stirred for 18 h at room temperature. 5 
mL brine were added and the mixture was stirred for further 5 min. The mixture was three times extracted 
with Et2O, the organic layers were washed with brine and dried over MgSO4. The solvent was removed in 
vacuo and the crude product was purified by HPLC (HPLC (C18-ISIS) (H2O:MeOH = 80:20 {10 min}, 
gradient H2O:MeOH = 80:20 → 45:55 {30 min}, gradient H2O:MeOH = 45:55 → 20:80 {25 min}, 
gradient H2O:MeOH = 20:80 → 10:90 {30 min}, gradient H2O:MeOH = 10:90 → 0:100 {5 min}, 
2.5 mL/min → 3.5 mL/min). After drying in vacuo, 7.2 mg (14 µmol, tR = 72.5 min) of a colourless oil 
were obtained (70% yield). 
1
H NMR (500 MHz, CDCl3)  5.93-6.01 (m, 1 H, NH), 5.69-5.79 (m, 1 H, CH=CHCH2), 5.37-5.47 (m, 
1 H, CH=CHCH2), 4.22-4.26 (m, 1 H, CHOH), 3.67-3.71 (m, 1 H, CHOTBS), 3.68 (d, J = 5.6 Hz, 1 H, 
OMe), 3.42-3.56 (m, 2 H, NHCH2), 3.04-3.14 (m, 2 H, CH2S), 2.75-2.81 (m, 2 H, CHCH3, CHCOOH), 
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2.45-2.51 (m, 1 H, CH), 2.20-2.30 (m, 1 H, OH), 1.98 (s, 3 H, CHCH3), 1.88-1.95 (m, 1 H, 1x 
CH2CHCOOH), 1.73-1.82 (m, 2 H, 1x CH2CHCOOH, 1x CH2CH), 1.63-1.68 (m, 2 H, CH2CH2CH), 
1.37-1.45 (m, 1 H, 1x CH2CH), 1.16 (d, J = 7.0 Hz, 3 H, CH3CO), 0.90 (s, 9 H, OSi(CH3)2C(CH3)3), 0.08 
(dd, J1 = 2.8 Hz, J2 = 1.7 Hz, 6 H, OSi(CH3)2C(CH3)3); 
13
C NMR (125 MHz, CDCl3) 203.4 (q, 1 C, 
SCO), 177.8 (q, 1 C, COOCH3), 170.4 (q, 1 C, CH3CONH), 132.4 (t, 1 C, CH=CHCH2), 130.5 (t, 1 C, 
CH=CHCH2), 75.4 (t, 1 C, CHOTBS), 74.2 (t, 1 C, CHOH), 54.1 (t, 1 C, CHCH3), 51.6 (p, 1 C, OMe), 
47.2 (t, 1 C, CHCOOH), 44.5 (t, 1 C, CH), 39.4 (s, 1 C, NHCH2), 38.8 (s, 1 C, CH=CHCH2), 32.1 (s, 1 C, 
CH2CHCOOH), 30.2 (s, 1 C, CH2CH2CH), 26.1 (s, 1 C, CH2S), 25.8 (p, 3 C, OSi(CH3)2C(CH3)3), 23.3 
(s, 1 C, CH2CH2CH), 18.0 (q, 1 C, OSi(CH3)2C(CH3)3), 15.0 (p, 1 C, CHCH3), -4.1 (p, 2 C, 
OSi(CH3)2C(CH3)3); HRMS (ESI) m/z calculated for C25H46NO6SSi [M+H]
+
: 516.2815, found: 
516.2820. 
 
(1R,2R)-methyl 2-{(1S,5R,6R,E)-7-[(2-acetamidoethyl)thio)-1,5-dihydroxy-6-methyl-7-oxo hept-3-en-1-
yl}cyclopentancarboxylate 
 
30 mg (58 µmol, 1.0 equiv.) of the bis-protected SNAc ester were dissolved in a mixture of 
THF:HCOOH:H2O (6:3:1, 2 mL) and stirred for 48 h at ambient temperature. 5 mL saturated NaHCO3 
solution were added and the aqueous layer was three times extracted with EtOAc. The organic layers 
were dried over MgSO4 and the solvent was removed under reduced pressure. Free TBS side products 
were removed by azeotropic distillation with toluene and the crude product was used in the next step 
without further purification. 
HRMS (ESI) m/z calculated for C19H31NO6S [M+H]
+
: 402.1950, found: 402.1936. 
 
(1R,2R)-2-{(1S,5R,6R,E)-7-[(2-acetamidoethyl)thio)-1,5-dihydroxy-6-methyl-7-oxohept-3-en-1-
yl}cyclopentanecarboxylic acid (17a and 17b) 
 
The crude material (50 µmol) was dissolved in 2 mL phosphate buffer (pH 8) and 100 units of porcine 
liver esterase were added. It was stirred for 5 d at room temperature during which the course of the 
reaction was monitored by LC-MS. The reaction mixture was three times extracted with EtOAc as well as 
EtOAc/iPrOH (3:1, 1.5 mL) and the solvent was removed in vacuo. The crude product was purified by 
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preparative HPLC (C18-ISIS) (H2O:MeCN = 80:20 {10 min}, gradient H2O:MeCN = 80:20 → 0:100 
{80 min}, H2O:MeCN = 0:100 {10 min}, 15 mL/min). After drying in vacuo, 18 mg (46.5 µmol, tR = 
40.0 min) of the colourless oil, which contains a mixture of 17a and 17b, were obtained with full 
conversion and an isolated yield of 81% over two steps. 
1
H NMR (400 MHz, CD2Cl2)  6.07 (bs, 1 H, NH), 5.72-5.81 (m, 1 H, CH=CHCH2), 5.65 (dd, J1 = 
15.4 Hz, J2 = 6.5 Hz, 1 H, CH=CHCH2), 4.24-4.31 (m, 1 H, CHOH), 3.53-3.60 (m, 1 H, CH2CHOH), 
3.38-3.48 (m, 2 H, NHCH2), 3.04-3.11 (m, 1 H, 1x CH2S), 2.93-3.01 (m, 1 H, 1x CH2S), 2.84-2.90 (m, 
1 H, CHCH3), 2.75-2.81 (m, 1 H, CHCOOH), 2.44-2.51 (m, 1 H, 1x CH=CHCH2), 2.05-2.24 (m, 3 H, 1x 
CH=CHCH2, CH, 1x CH2CH), 1.97 (s, 3 H, CH3CO), 1.80-1.92 (m, 2 H, CH2CHCOOH), 1.58-1.74 (m, 
2 H, CH2CH2CH), 1.26-1.34 (m, 1 H, CH2CH2CH), 1.22 (d, J = 7.2 Hz, 3 H, CHCH3); 
13
C NMR (100 
MHz, CD2Cl2)  203.0 (q, 1 C, SCO), 176.6 (q, 1 C, COOH), 171.2 (q, 1 C, CH3CONH) , 134.2 (t, 1 C, 
CH=CHCH2), 128.4 (t, 1 C, CH=CHCH2), 75.9 (t, 1 C, CH2CHOH), 74.8 (t, 1 C, CHOH), 54.2 (t, 1 C, 
CHCH3), 48.9 (t, 1 C, CH), 48.2 (t, 1 C, CHCOOH), 39.1 (s, 1 C, NHCH2), 38.9 (s, 1 C, CH=CHCH2), 
30.6 (s, 1 C, CH2CHCOOH), 29.3 (s, 1 C, CH2CH2CH), 28.8 (s, 1 C, CH2CH2S ), 25.7 (s, 1 C, 
CH2CH2CH), 22.9 (p, 1 C, CH3CO), 14.0 (p, 1 C, CHCH3); HRMS (ESI) m/z calculated for C18H30NO6S 
[M+H]+: 388.1794, found: 388.1794. 
 
(1R,2R)-methyl 2-((S,7E,9E)-2,2,3,3,10-pentamethyl-11,16-dioxo-4-oxa-12-thia-15-aza-3-silaheptadeca-
7,9-dien-5-yl)cyclopentanecarboxylate 
 
5 mg (14.2 µmol, 1 equiv.) of 16 were subjected to metathesis reaction as described before. The product 
from this reaction was dissolved in 1 mL of CH2Cl2 and 7.2 mg (16.5 µmol, 1.2 equiv.) of 21 were added. 
The solution was stirred at 50 °C overnight and the solvent was removed under reduced pressure. The 
crude material was purified by flash chromatography on silica gel (petroleum ether:EtOAc (1:1)). After 
drying in vacuo, 6.4 mg (12.5 µmol) of a colourless oil were obtained (88% yield over two steps).  
Rf = 0.11 (PE/EtOAc 9:1); [α]D
23
 = +8.0 (c = 0.6, CH2Cl2); 
1
H NMR (500 MHz, Acetone-d6) 7.17 (d, J 
= 11.1 Hz, 1 H, C=CHCH), 6.53 (dd, J1 = 11.1 Hz, J2 = 15.0 Hz, 1 H, CH=CHCH2), 6.24-6.31 (m, 1 
H,CH=CHCH2), 3.86 (q, J = 5.7 Hz, 1 H, CHOTBS), 3.62 (s, 3 H, OMe), 3.32 (q, J = 6.5 Hz, 2 H, 
NHCH2), 3.01-3.07 (m, 2 H, CH2S), 2.75-2.85 (m, 1 H, CHCOOMe), 2.43-2.53 (m, 3 H, CH, 
CH=CHCH2), 1.96 (s, 3 H, CH3CO), 1.86 (s, 3 H, CHCH3), 1.82-1.86 (m, 2 H, CH2CHCOOH), 1.68-1.82 
(m, 1 H, 1x CH2CH2CH), 1.55-1.67 (m, 2 H, CH2CH2CH), 1.42-1.52 (m, 1H, 1x CH2CH2CH), 0.90 (s, 9 
H, OSi(CH3)2C(CH3)3), 0.11 (2 s, 6 H, OSi(CH3)2C(CH3)3); 
13
C NMR (125 MHz, Acetone-d6)  192.9 (1 
C, q, SCO), 177.4 (1 C, q, COOCH3), 170.1 (1 C, q, CH3CONH), 141.4 (1 C, t, CH=CHCH2), 138.0 (1 C, 
t, CHCH=CH), 134.0 (1 C, q, CH3C) 128.9 (1 C, t, CH=CHCH2), 75.2 (1 C, t, CH2CHOTBS), 51.8 (1 C, 
p, COOCH3), 48.7 (1 C, t, CH), 45.5 (1 C, t, CHCOOCH3), 40.5 (1 C, s, CH2CHOTBS), 39.7 (1 C, s, 
NHCH2), 32.6 (1 C, s, CH2CHCOOCH3), 30.6 (1 C, s, CH2S), 29.2 (1 C, s, CH2CH2CH), 26.7 (1 C, s, 
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CH2CH2CH), 26.3 (3 C, p, OSi(CH3)2C(CH3)3), 22.8 (1 C, p, CH3C), 18.6 (1 C, q, OSi(CH3)2C(CH3)3), 
12.7 (1 C, p, CH3CONH), -3.9 (1 C, p, OSi(CH3)2C(CH3)3), -4.5 (1 C, p, OSi(CH3)2C(CH3)3); HRMS 
(ESI) m/z calculated for C25H44NO5SSi [M+H]
+
: 498.2709, found: 498.2688. 
 
(1R,2R)-methyl 2-((S,3E,5E)-7-((2-acetamidoethyl)thio)-1-hydroxy-6-methyl-7-oxohepta-3,5-dien-1-
yl)cyclopentanecarboxylate 
 
3.2 mg (6.4 µmol, 1 equiv.) of the TBS-protected precursor were dissolved in 2 mL of THF : HCOOH : 
H2O (6 : 3 : 1) and stirred at room temperature. After two days, the reaction was quenched by the addition 
of saturated NaHCO3 solution. After extraction with EtOAc, the combined organic layers were dried over 
MgSO4 and the solvent removed under reduced pressure. The crude product, which was obtained as a 
colourless oil, was analysed by 
1
H NMR spectroscopy and directly subjected to esterase-catalysed 
deprotection. 
The crude material from another entry was purified by HPLC for full spectroscopic characterisation (C18-
P) (H2O : MeOH = 90:10 {5 min}, gradient H2O:MeOH = 90:10 → 45:55 {45 min}, gradient H2O:MeOH 
= 45:55 → 0:100 {30 min}, H2O:MeOH = 0:100 {20 min}, 2.25 mL/min).   
[α]D
23
 = -1.0 (c = 0.1, CH2Cl2); 
1
H NMR (500 MHz, acetone-d6)  7.26 (bs, 1 H, NH), 7.16 (d, J = 11.7 
Hz, 1 H, C=CHCH), 6.54 (dd, J1 = 13.7 Hz, J2 = 11.66 Hz, 1 H, CH=CHCH2), 6.29-6.37 (m, 1 H, 
CH=CHCH2), 3.61 (s, 3 H, OMe), 3.57-3.63 (m, 1 H,CHOH), 3.29-3.36 (m, 2 H, CH2NH), 3.02-3.07 (m, 
2 H, CH2S), 2.75-2.78 (m, 1 H, CHCOOCH3), 2.42-2.52 (m, 1 H, 1x CH=CHCH2), 2.29-2.39 (m, 2 H, 1x 
CH=CHCH2, CHCHOH), 1.95 (s, 3 H, CH3CO), 1.87-1.93 (m, 1 H, 1x CH2CHCOOCH3), 1.85 (s, 3 H, 
CH3C=CH), 1.70-1.80 (m, 2 H, 1x CH2CHCOOCH3, 1x CH2CH2CH), 1.61-1.68 (m, 2 H, CH2CH2CH), 
1.41-1.50 (m, 1 H, 1x CH2CH2CH); 
13
C NMR (125 MHz, acetone-d6) 192.9 (1 C, q, SCO), 177.7 (1 C, 
q, COOCH3), 170.0 (1 C, q, CONH), 142.7 (1 C, t, CH=CHCH2), 138.3 (1 C, t, CCH=CH), 133.8 (1 C, q, 
CCH=CH), 128.4 (1 C, t, CHCH=CH), 74.5 (1 C, t, CHOH), 51.7 (1 C, p, COOCH3), 50.2 (1 C, t, 
CHCHOH), 46.7 (1 C, t, CHCOOCH3), 41.1 (1 C, s, CH=CHCH2), 39.8 (1 C, s, CH2NH), 32.2 (1 C, s, 
CH2CHCOOCH3), 30.5 (1 C, s, CH2CH2CH), 29.1 (1 C, s, CH2S), 26.4 (1 C, s, CH2CH2CH), 22.9 (1 C, 
p, CH3C), 12.7 (1 C, p, CH3CO); HRMS (ESI) m/z calculated for C19H29NO5SNa [M+Na]
+
: 406.1634, 
found: 406.1633. 
 
(1R,2R)-2-((S,3E,5E)-7-((2-acetamidoethyl)thio)-1-hydroxy-6-methyl-7-oxohepta-3,5-dien-1-
yl)cyclopentane-1-carboxylic acid (18) 
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The crude material from the TBS deprotection was dissolved in 1 mL phosphate buffer (pH 8) and 100 
units of porcine liver esterase were added. It was stirred for 3 d at ambient temperature during which the 
course of the reaction was monitored by LC-MS. After conversion was complete, the crude material was 
purified by flash chromatography on C18-reversed phase silica gel (H2O then MeCN:H2O (1:4)).  After 
drying in vacuo, 1.6 mg (4.3 µmol) of the colourless oil 18 were obtained (67% yield over two steps). 
Compound 18 showed partial decomposition after chromatography. 
1
H NMR (400 MHz, CDCl3)  7.17 (d, J = 11.1 Hz, 1 H, C=CHCH), 6.48 (dd, J1 = 11.1 Hz, J2 = 15.0 
Hz, 1 H, CHCH=CH), 6.17-6.27 (m, 1 H, CH=CHCH2), 5.92-6.06 (m, 1 H, NH), 4.68 (s, 1 H, OH), 3.58-
3.67 (m, 1 H,CHOH), 3.46 (dt, 2 H, J1 = 6.4 Hz, J2 = 5.9 Hz, CH2NH), 3.09 (t, 2 H, J = 6.3 Hz, CH2S), 
2.77 (dt, 1 H, J1 = 6.8 Hz, J2 = 7.9 Hz, CHCOOCH3), 2.54-2.64 (m, 1 H, 1x CH=CHCH2), 2.04-2.38 (m, 
3 H, 1x CH=CHCH2, CHCHOH, 1x CH2CHCOOCH3), 1.95-2.02 (2x s, 6 H, CH3CO, CH=CCH3), 1.80-
1.94 (m, 2 H, 1x CH2CHCOOCH3, 1x CH2CH2CH), 1.61-1.73 (m, 2 H, CH2CH2CH), 1.27-1.33 (m, 1 H, 
1x CH2CH2CH); 
13
C NMR (100 MHz, CDCl3) 193.9 (1 C, q, SCO), 178.1 (1 C, q, COOH), 170.7 (1 C, 
q, CONH), 139.5 (1 C, t, CH=CHCH2), 137.3 (1 C, t, CCH=CH), 133.9 (1 C, q, CCH=CH), 129.1 (1 C, t, 
CHCH=CH), 75.9 (1 C, t, CHOH), 49.2 (1 C, t, CHCHOH), 48.3 (1 C, t, CHCOOH), 40.5 (1 C, s, 
CH=CHCH2), 40.0 (1 C, s, CH2NH), 30.7 (1 C, s, CH2CH2CH), 29.9 (1 C, s, CH2CHCOOH), 28.7 (1 C, 
s, CH2S), 25.8 (1 C, s, CH2CH2CH), 23.4 (1 C, p, CH3C), 12.9 (1 C, p, CH3CO); HRMS (ESI) m/z 
calculated for C18H26NO5S [M-H]
-
: 368.1532, found: 368.1523. 
  
(1R,2R)-methyl 2-{(S,3E,5E)-1-[(tert-butyldimethylsilyl)oxy]-7-methoxy-6-methyl-7-oxo-hepta-3,5-
diene-1-yl}cyclopentane carboxylate 
 
8.8 mg (28 µmol, 1.0 equiv.) of olefin 16 were subjected to olefin cross metathesis with crotonaldehyde 
and second generation Grubbs catalyst and purified as described previously. The resulting unsaturated 
aldehyde was solved in 2 mL CH2Cl2 and 11 mg (31 µmol, 1.1 equiv) of 22 were added. The resulting 
solution was stirred at 50 °C for 21 h. The solvent was removed under reduced pressure and the crude 
product was purified by flash chromatography on C18-reversed phase silica gel (MeCN:H2O (2:3)). After 
drying in vacuo, 7.4 mg (18 µmol) of a colourless oil, the E,E-configured methyl ester, were obtained 
(64% yield over two steps). 
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Rf = 0.4 (PE/EtOAc 9:1); [α]D
23
 = +5.8 (c = 0.7, CH2Cl2); 
1
H NMR (500 MHz, benzene-d6)  7.46 (d, J = 
11.4 Hz, 1 H, C=CHCH), 6.37 (dd, J1 = 12.5 Hz, J2 = 13.9 Hz, 1 H, CH=CHCH2), 5.90-5.96 (m, 1 H, 
CH=CHCH2), 3.53-3.57 (m, 1 H, CHOTBS), 3.44 (s, 3 H, OCH3), 3.37 (s, 3 H, OCH3), 2.81-2.87 (m, 
1 H, CHCOOCH3), 2.58-2.64 (m, 1 H, CH2CH2CH), 2.29-2.38 (m, 1 H, CH2CHOTBS), 2.21-2.26 (m, 
1 H, CH2CHOTBS), 1.99 (s, 3 H, CH3CCH), 1.78-1.88 (m, 2 H, CH2CHCOOCH3), 1.62-1.70 (m, 1 H, 1x 
CH2CH2CH), 1.55-1.62 (m, 1 H, 1x CH2CH2CH), 1.47-1.54 (m, 1 H, CH2CH2CH), 1.27-1.32 (m, 1 H, 
CH2CH2CH), 0.94 (s, 9 H, OSi(CH3)2C(CH3)3), 0.04 (s, 3 H, OSi(CH3)2C(CH3)3), 0.01 (s, 3 H, 
OSi(CH3)2C(CH3)3); 
13
C NMR (125 MHz, benzene-d6)  176.8 (q, 1 C, CHCOOCH3), 168.5 (q, 1 C, 
CCOOCH3), 138.6 (t, 1 C, CH=CHCH2), 138.5 (t, 1 C, CCH=CH), 128.9 (t, 1 C, CH=CHCH2), 126.2 (q, 
1 C, CH3CCH), 74.7 (t, 1 C, CHOTBS), 51.4 (p, 1 C, OCH3), 51.3 (p, 1 C, OCH3), 48.2 (t, 1 C, 
CHCOOCH3), 44.8 (t, 1 C, CH2CH2CH), 40.3 (s, 1 C, CH2CHOTBS), 32.3 (s, 1 C, CH2CHCOOCH3), 
30.3 (s, 1 C, CH2CH2CH), 26.5 (s, 1 C, CH2CH2CH), 26.1 (p, 3 C, OSi(CH3)2C(CH3)3), 18.3 (q, 1 C, 
OSi(CH3)2C(CH3)3), 12.9 (p, 1 C, CH3CCH), -3.9 (s, 1 C, OSi(CH3)2C(CH3)3), -4.4 (s, 1 C, 
OSi(CH3)2C(CH3)3); HRMS (ESI) m/z calculated for C22H39O5Si [M+H]
+
: 411.2567, found: 411.2563. 
 
(1R,2R)-methyl 2-{(S,3E,5E)-1-hydroxy-7-methoxy-6-methyl-7-oxohepta-3,5-dien-1-yl} 
cyclopentancarboxylat (19) 
 
7.4 mg (18 µmol, 1 equiv.) of the TBS-protected precursor were dissolved in 2 mL THF : HCOOH : H2O 
(6 : 3 : 1) and stirred at room temperature. Monitoring of the reaction by LC-MS showed full conversion 
after two days and the reaction was quenched by the addition of saturated NaHCO3 solution. After 
extraction with EtOAc, the combined organic layers were dried over MgSO4 and the solvent removed 
under reduced pressure. The crude material was purified by flash chromatography on C18-reversed phase 
silica gel (H2O then MeCN:H2O (1:4)). After drying in vacuo, 3.3 mg (11.1 µmol) of the colourless oil 19 
were obtained (62% yield).  
Rf = 0.21 (PE/EtOAc 9:1); [α]D
23
 = -1.0 (c = 0.1, CH2Cl2); 
1
H NMR (400 MHz, CDCl3)  7.17 (d, J = 
11.4 Hz, 1 H, C=CH=CH), 6.43 (dt, J1 = 14.9 Hz, J2 = 11.3 Hz, 1 H, CH=CHCH2), 6.13 (dt, J1 = 14.9 Hz, 
J2 = 7.5 Hz, 1 H, CH=CHCH2), 3.75 (s, 3 H, OCH3), 3.70 (s, 3 H, OCH3), 3.13-3.17 (dt, J1 = 3.1 Hz, J2 = 
8.1 Hz, 1 H, CHOH), 2.71 (dt, J1 = 8.2 Hz, J2 = 8.2 Hz, 1 H, CHCOOCH3), 2.44-2.54 (m, 1 H, 
CHCH2CHOTBS), 2.22-2.34 (m, 2 H, 1x CHCH2CHOTBS, 1x CHCHCHOH), 1.93 (s, 3 H, CH3CCH), 
1.91-2.00 (m, 1 H, 1x CH2CHCOOH), 1.81-1.91 (m, 2 H, 1x CH2CHCOOH, 1x CH2CH), 1.64-1.74 (m, 
2 H, CH2CH2CH), 1.22-1.38 (m, 1 H, 1x CH2CH); 
13
C NMR (100 MHz, CDCl3)  177.7 (q, 1 C, 
CHCOOCH3), 169.2 (q, 1 C, CCOOCH3), 138.4 (t, 2 C, CH=CHCH2, CCH=CH), 128.9 (t, 1 C, 
CH=CHCH2), 126.0 (q, 1 C, CH3CCH), 75.3 (t, 1 C, CHOH), 52.1 (p, 1 C, OCH3), 51.9 (p, 1 C, OCH3), 
49.7 (t, 1 C, CHCOOCH3), 47.8 (t, 1 C, CH2CH2CH), 40.4 (s, 1 C, CHCH2CHOH), 31.1 (s, 1 C, 
CH2CHCOOCH3), 30.0 (s, 1 C, CH2CH2CH), 25.5 (s, 1 C, CH2CH2CH2), 12.8 (p, 1 C, CH3CCH); 
HRMS (ESI) m/z calculated for C16H24O5Na [M+Na]
+
: 319.1521, found: 319.1525. 
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(1R,2R)-methyl 2-{(S,3E,5Z)-1-[(tert-butyldimethylsilyl)oxy]-7-methoxy-6-methyl-7-oxo-hepta-3,5-
diene-1-yl}cyclopentane carboxylate 
 
190 mg (720 µmol, 12 equiv.) 18-crown-6 and 50 mg (360 µmol, 6 equiv.) K2CO3 were suspended in 2 
mL toluene and stirred for 1 h at room temperature. The suspension was cooled to -20 °C and 20 mg 
(6 µmol, 1 equiv.) 23 were added. 25 mg (60 µmol, 1.0 equiv.) of the precursor aldehyde were added and 
the reaction was stirred for further 5 h at 0 °C. After the addition of 10 mL brine, the aqueous layer was 
three times extracted with Et2O and the organic layers were dried over MgSO4. The solvent was removed 
under reduced pressure and the crude product was purified by flash chromatography on silica gel 
(petroleum ether:EtOAc (50:1) then petroleum ether:EtOAc (20:1) and petroleum ether:EtOAc (10:1)). 
After drying in vacuo, 11 mg (28 µL) of a colourless oil were obtained (47% yield over two steps). 
Rf = 0.6 (PE/EtOAc 9:1); [α]D
23
 = +14.4 (c = 0.8, CH2Cl2); 
1
H NMR (500 MHz, benzene-d6)  7.64 (dd, 
J1 = 12.5 Hz, J2 = 13.8 Hz, 1 H, CH=CHCH2), 6.27 (d, J = 10.9 Hz, 1 H, C=CH=CH), 5.93-6.01 (m, 1 H, 
CH=CHCH2), 3.57-3.61 (m, 1 H, CHOTBS), 3.44 (s, 3 H, OCH3), 3.40 (s, 3 H, OCH3), 2.80-2.86 (m, 
1 H, CHCOOCH3), 2.66-2.73 (m, 1 H, CH2CH2CH), 2.28-2.43 (m, 2 H, CH2CHOTBS), 1.87 (s, 3 H, 
CH3CCH), 1.77-1.86 (m, 2 H, CH2CHCOOCH3), 1.64-1.73 (m, 1 H, CH2CH2CH), 1.54-1.62 (m, 1 H, 
CH2CH2CH), 1.45-1.53 (m, 1 H, CH2CH2CH), 1.20-1.29 (m, 1 H, CH2CH2CH), 0.98 (s, 9 H, 
OSi(CH3)2C(CH3)3), 0.06 (s, 3 H, OSi(CH3)2C(CH3)3), 0.05 (s, 3 H, OSi(CH3)2C(CH3)3); 
13
C NMR (125 
MHz, benzene-d6)  176.9 (q, 1 C, CHCOOCH3), 167.5 (q, 1 C, CCOOCH3), 141.3 (t, 1 C, CH=CHCH2), 
137.5 (t, 1 C, CCH=CH), 130.9 (t, 1 C, CH=CHCH2), 124.7 (q, 1 C, CH3CCH), 75.2 (t, 1 C, CHOTBS), 
51.3 (p, 1 C, OCH3), 50.9 (p, 1 C, OCH3), 48.2 (t, 1 C, CHCOOCH3), 45.3 (t, 1 C, CH2CH2CH), 39.7 (s, 
1 C, CH2CHOTBS), 32.3 (s, 1 C, CH2CHCOOCH3), 30.2 (s, 1 C, CH2CH2CH), 26.4 (s, 1 C, 
CH2CH2CH), 26.2 (p, 3 C, OSi(CH3)2C(CH3)3), 20.9 (q, 1 C, OSi(CH3)2C(CH3)3), 18.3 (p, 1 C, 
CH3CCH), -3.9 (s, 1 C, OSi(CH3)2C(CH3)3), -4.5 (s, 1 C, OSi(CH3)2C(CH3)3); HRMS (ESI) m/z 
calculated for C22H38O5NaSi [M+Na]
+
: 433.2386, found: 433.2387. 
 
(1R,2R)-methyl 2-{(S,3E,5Z)-1-hydroxy-7-methoxy-6-methyl-7-oxohepta-3,5-dien-1-yl} 
cyclopentancarboxylat (20) 
 
11 
 
2 mg (7 µmol, 1 equiv.) of the TBS-protected precursor were dissolved in 1 mL of THF:HCOOH:H2O 
(6:3:1) and stirred at room temperature. Monitoring of the reaction by LC-MS showed full conversion 
after two days and the reaction was quenched by the addition of saturated NaHCO3 solution. After 
extraction with EtOAc, the combined organic layers were dried over MgSO4 and the solvent removed 
under reduced pressure. The crude material was purified by HPLC (C18-P[B]) (H2O:MeOH = 80:20 
{5 min}, gradient H2O:MeOH = 80:20 → 0:100 {95 min}, 4 mL/min → 5 mL/min). After drying in 
vacuo, 1 mg (4 µmol, tR=72.3 min) of the colourless oil 20 was obtained (57% yield).  
[α]D
23
 = +1.0 (c = 0.1, CH2Cl2); 
1
H NMR (500 MHz, benzene-d6)  7.14-7.20 (m, 1 H, CH=CHCH2), 
6.42 (d, J = 11.2 Hz, 1 H, C=CH=CH), 5.94-6.01 (m, 1 H, CH=CHCH2), 3.76 (s, 3 H, OCH3), 3.69 (s, 
3 H, OCH3), 3.64-3.67 (m, 1 H, CHOH), 3.48-3.54 (m, 2 H, CH2CHOTBS), 2.66-2.72 (m, 1 H, 
CHCOOCH3), 1.95 (s, 3 H, CH3CCH), 1.17-1.89 (m, 6 H, 3x CH2(cyclopentane)); HRMS (ESI) m/z 
calculated for C16H24O5Na [M+Na]
+
: 319.1521, found: 319.1516. 
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Protein expression and purification 
Plasmids pET28a(+)-BorDH2, pET28a(+)-BorDH3 and pET28a(+)-BorDH3-H48A were available from 
a previous study.
[2]
 For protein expression, chemically competent E. coli BL21(DE3)-CodonPlus-RP cells 
were transformed with the corresponding plasmids. Single colonies were used to inoculate 50-100 mL 
2TY medium (16 g tryptone (Duchefa), 10 g yeast extract (Sigma), 5 g NaCl in 1 L). Cultures were 
grown to an OD600 of 0.6 at 37 °C, protein production was induced with 0.1 mM IPTG and shaken at 
room temperature for 22 hours. Cells were harvested by centrifugation (4,500 rpm, 4 °C, 30 min) and 
stored at -20 °C. 
 
Figure S1: SDS-PAGE after protein purification by affinity chromatography; L: lysate, p: pellet, FT: flow through, W1-W2: 
wash steps, E1-E3: elution steps, M: Marker (PageRuler Plus Prestained Protein Ladder). 
For purification, approximately 2 g cells were resuspended in 20 mL Binding Buffer (40 mM Tris-HCl, 
100 mM NaCl, pH 7.8) and broken by cell disruption in a French Press. After centrifugation at 8,500 rpm 
for 45 min the resulting crude extract was passed through a Ni-NTA column (1-2 mL bed volume), the 
column was washed sequentially with each 5 column volumes of binding buffer containing 0 mM 
imidazole and 20 mM imidazole. The target protein was eluted with each 5 column volumes of 100 mM, 
200 mM and 500 mM imidazole in Binding Buffer (Figure S1). Finally the eluate was concentrated, the 
buffer was replaced by Storage Buffer (25 mM Hepes, 150 mM NaCl, pH 6.8) and immediately used for 
activity assays. Alternatively, the protein solution was supplemented with 50% glycerol and stored at -20 
°C. 
  
kDa 
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Enzyme activity assays 
Activity assays were carried out in a total volume of 100 μL containing 12 mM of 17a/b and up to 3 
mg/mL of the corresponding BorDH enzyme in 25 mM HEPES (pH 7.5, 100 mM NaCl). Reactions were 
incubated at 37 °C for 16 h and extracted with 3 x 1 mL of ethyl acetate. After evaporation of the solvent, 
the sample was resuspended in 50 μL of methanol and analysed by UPLC-MS. All traces were compared 
to authentic standards. Reactions without enzyme or active site mutants served as controls.  
A)  
Enzyme-free control assay 
14 
 
B)  
C)  
BorDH3 mutant assay 
BorDH2 assay 
15 
 
D)  
Figure S2: UPLC-MS analysis of the conversion assays with substrate 17a/b. a) Enzyme-free overnight incubation of 17a/b; 
b) overnight incubation of 17a/b with BorDH3-H49A; c) overnight incubation of 17a/b with BorDH2; d) overnight incubation 
of 17a/b with BorDH3; [M+Na]
+
 (17a/b) = 410, [M+Na]
+
 (18) = 392; x-axis: retention time, y-axis: relative intensity. 
Product derivatization and configuration analysis 
For determination of the product configuration, the assay products were transformed into the 
corresponding bis-methylesters. Therefore, the crude mixtures were treated with 50 µL of 0.5 M NaOH in 
50 µL THF and 50 µL H2O for 30 min. After acidification with 2 M HCl to pH 6, the solvent was 
removed under reduced pressure. Methylation occurred by treatment with 20 µL of 
trimethylsilyldiazomethane (10% in hexane) in methanol/toluene for 15 min. The derivatization products 
were compared to synthetic standards by UPLC-MS. 
A)  
(Z)-isomer 20 
BorDH3 assay 
16 
 
B)  
C)  
D)  
Figure S3: UPLC-MS analysis of derivatized assay products and comparison to reference molecules. A) (Z)-isomer, reference 
bis-methylester 20; B) (E)-isomer, reference bis-methylester 19; C) derivatized dehydration product of BorDH2; D) derivatized 
dehydration product of BorDH3; [M+Na]
+
 (19/20) = 319; x-axis: retention time, y-axis: relative intensity. 
(E)-isomer 19 
BorDH2 assay 
BorDH3 assay 
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A)   
B)  
C)  
BorDH2 spiked with (Z)-isomer 
BorDH2 spiked with (E)-isomer 
BorDH3 spiked with (Z)-isomer 
18 
 
D)  
Figure S4: UPLC-MS runs of derivatized assay products, which were spiked with the respective isomers 19 or 20 before 
analysis. A) BorDH2 assayed with 17a/b, spiked with 20; B) BorDH2 assayed with 17a/b, spiked with 19; C) BorDH3 assayed 
with 17a/b, spiked with 20; D) BorDH3 assayed with 17a/b, spiked with 19; [M+Na]
+
 (19/20) = 319; x-axis: retention time, y-
axis: relative intensity. 
NMR analysis of the large-scale BorDH3 assay 
10 mg 17a/b were incubated with 6 mg/mL BorDH3 in 25 mM HEPES (pH7.5, 100 mM NaCl) at 37 °C 
for 16 h (end volume 1 mL). The sample was 3 times extracted with EtOAc and the solvent was removed 
in vacuo. The sample was dissolved in CD2Cl2 and the resulting NMR spectrum was compared to the 
spectrum of synthetic 18. The chemical shifts of the olefinic protons H3, H4 and H5 correlate to (2E,4E)-
configuration of the diene (Figure S5). 
A)  
BorDH3 spiked with (E)-isomer 
19 
 
B)  
C)  
20 
 
D)  
Figure S5: A) 
1
H NMR spectrum of an incubation of 17a/b with BorDH3 (CD2Cl2, 500 MHz). B) 
1
H NMR spectrum of 
synthetic 18 (CDCl3, 400 MHz); C) 
1
H NMR spectrum of synthetic 17a/b (CD2Cl2, 400 MHz); D) Structures of the BorDH3 
precursor and the BorDH3 product. 
NMR analysis of pre-borrelidin 
Pre-borrelidin was isolated from the mutant strain M19B9I1 as previously described.
[3]
 The previous 
NMR assignments for pre-borrelidin were confirmed using 
1
H, 
13
C, DEPT, COSY, HSQC and HMBC 
experiments. The observed 
3
J coupling constants are consistent with either of the (12Z,14E) or (12E,14E)-
configurations as shown in Figure S6. 
A)  
B)  
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C)  
Figure S6: A) Structures of the potential configurational isomers of pre-borrelidin; B) 
1
H NMR spectrum of pre-borrelidin 9a 
(CDCl3, 500 MHz); C) 
13
C NMR spectrum of pre-borrelidin 9a (CDCl3, 125 MHz). 
To determine the configuration of the C12-C13 double bond a NOESY experiment was performed and 
the data are summarised in Table S1 and Figure S7. In accordance with a 12E configuration, a strong 
correlation for the methyl group attached to C12 to both H14 and H11 is visible. In contrast there is no 
correlation between the methyl group attached to C12 and H13, which would be expected for 12Z. 
Table S1: 
1
H NMR spectrum of pre-borrelidin and listing of selected NMR data for pre-borrelidin (CDCl3, 500 MHz). 
Position Chemical shift 
(ppm) 
J (Hz) NOESY correlations  
H10 1.60 m 10-CH3 
H11 3.53 9 (d) H13, 10-CH3, 12-CH3 
H12 - - - 
H13 5.84 11.0 (d) H11, H14(w), H15 
H14 6.28 1.8, 11.0, 14.9 (ddd) H13(w), H16a, 12-CH3 
H15 5.48 3.5, 10.7, 14.9 (ddd) H13, H16b, H17 
H16a 
H16b 
2.22 
2.53 
m H14, H16b 
H15, H16a, H17 
H17 5.10 2.9, 8.0, 11.3 (ddd) H15, H16b, H19 
10-CH3 0.94 6.5 (d) H9, H10, H11, 8-CH3, 12-CH3 
12-CH3 1.64 s H11, H14, 10-CH3 
 
22 
 
 
 
Figure S7: NOESY spectrum and correlations of pre-borrelidin (CDCl3, 500 MHz). The correlations between 12-CH3 and H14 
as well as between H11 and H13 are highlighted in orange. 
In a gradient NOE irradiating at 5.84 ppm (H13) strong correlations to H11 and H15 (and very weak 
signal to H14) and no correlation to the 12-CH3 group were observed. These combined data firmly 
establish the geometry of pre-borrelidin as (12E,14E). 
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Figure S8: NOE correlation spectrum of pre-borrelidin (CDCl3, 500 MHz). Irradiation on proton H13 led to a correlation to 
protons H11 and H15, which is in agreement to a 12E-configuration. 
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